From COVID-19 to the common cold: Scientists identify broadly-effective, infection-halting compound
Researchers have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold. Their testing yielded multiple GSK3 inhibitors that showed a high level of effectiveness against the coronaviruses and low toxicity to human cells. The leading compound, identified as T-1686568, inhibited both SARS-CoV-2 and the common cold virus, the main criteria the authors used in the search for broad-spectrum protection. The findings reveal a potential path toward antiviral treatments that could be used against many different pathogens.
Materials provided by University of British Columbia. Note: Content may be edited for style and length.
Source link aaaaa